↓ Skip to main content

An exploratory clinical trial on the efficacy and safety of glucagon-like peptide-1 receptor agonist dulaglutide in patients with type 2 diabetes on maintenance hemodialysis

Overview of attention for article published in Renal Replacement Therapy, June 2022
Altmetric Badge

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
13 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
An exploratory clinical trial on the efficacy and safety of glucagon-like peptide-1 receptor agonist dulaglutide in patients with type 2 diabetes on maintenance hemodialysis
Published in
Renal Replacement Therapy, June 2022
DOI 10.1186/s41100-022-00409-4
Authors

Daisuke Ugamura, Michihiro Hosojima, Hideyuki Kabasawa, Naohito Tanabe, Yuta Yoshizawa, Yoshiki Suzuki, Akihiko Saito, Ichiei Narita

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 13 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 13 100%

Demographic breakdown

Readers by professional status Count As %
Student > Doctoral Student 2 15%
Researcher 2 15%
Student > Ph. D. Student 1 8%
Student > Bachelor 1 8%
Unknown 7 54%
Readers by discipline Count As %
Medicine and Dentistry 3 23%
Nursing and Health Professions 2 15%
Unknown 8 62%